Healthcare provider profile · identity verified

Daniel L. Rosenberg, MD

Family Practice · CHARLOTTE, NC · NPI 1427151851

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	545	174
Amlodipine Besylate	Amlodipine Besylate	415	130
Lisinopril	Lisinopril	320	97
Losartan Potassium	Losartan Potassium	259	79
Levothyroxine Sodium	Levothyroxine Sodium	252	65
Omeprazole	Omeprazole	228	73
Rosuvastatin Calcium	Rosuvastatin Calcium	186	55
Furosemide	Furosemide	166	56
Famotidine	Famotidine	160	53
Fluticasone Propionate	Fluticasone Propionate	145	52
Metformin Hcl	Metformin Hcl	145	49
Metoprolol Succinate	Metoprolol Succinate	143	43
Simvastatin	Simvastatin	141	40
Gabapentin	Gabapentin	138	41
Tamsulosin Hcl	Tamsulosin Hcl	137	45
Carvedilol	Carvedilol	128	40
Albuterol Sulfate Hfa	Albuterol Sulfate	121	46
Trazodone Hcl	Trazodone Hcl	120	36
Duloxetine Hcl	Duloxetine Hcl	113	28
Bupropion Xl	Bupropion Hcl	112	32
Pravastatin Sodium	Pravastatin Sodium	94	29
Hydrochlorothiazide	Hydrochlorothiazide	92	26
Eliquis	Apixaban	91	30
Pantoprazole Sodium	Pantoprazole Sodium	91	30
Alprazolam	Alprazolam	79	20
Sertraline Hcl	Sertraline Hcl	76	27
Montelukast Sodium	Montelukast Sodium	75	23
Meloxicam	Meloxicam	74	30
Clopidogrel	Clopidogrel Bisulfate	73	21
Mounjaro	Tirzepatide	71	14
Potassium Chloride	Potassium Chloride	69	23
Atenolol	Atenolol	65	20
Triamcinolone Acetonide	Triamcinolone Acetonide	65	41
Prednisone	Prednisone	64	48
Zolpidem Tartrate	Zolpidem Tartrate	64	17
Spironolactone	Spironolactone	62	20
Nifedipine Er	Nifedipine	53	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	17
Allopurinol	Allopurinol	49	14
Metoprolol Tartrate	Metoprolol Tartrate	49	18
Diclofenac Sodium	Diclofenac Sodium	46	17
Finasteride	Finasteride	46	16
Metformin Hcl Er	Metformin Hcl	46	18
Oxybutynin Chloride Er	Oxybutynin Chloride	45	suppressed
Celecoxib	Celecoxib	44	15
Ondansetron Odt	Ondansetron	41	18
Trulicity	Dulaglutide	41	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	39	17
Tizanidine Hcl	Tizanidine Hcl	39	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	12
Hydralazine Hcl	Hydralazine Hcl	38	13
Tramadol Hcl	Tramadol Hcl	38	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	11
Ozempic	Semaglutide	34	11
Buspirone Hcl	Buspirone Hcl	33	11
Jardiance	Empagliflozin	33	12
Glipizide Er	Glipizide	32	suppressed
Januvia	Sitagliptin Phosphate	30	11
Mirtazapine	Mirtazapine	29	suppressed
Ramipril	Ramipril	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Ibuprofen	Ibuprofen	27	11
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Diazepam	Diazepam	25	suppressed
Torsemide	Torsemide	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Linzess	Linaclotide	23	suppressed
Nystatin	Nystatin	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Testosterone	Testosterone	23	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Naproxen	Naproxen	22	12
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Colchicine	Colchicine	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Lactulose	Lactulose	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Glipizide	Glipizide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error